MK-2206 is an orally active, highly selective, metabotropic Akt inhibitor that targets Akt1 [IC50: 8 nM], Akt2 [IC50: 12 nM], and Akt3 [IC50: 65 nM]. Many breast cancer cell lines, PIK3CA mutants, and PTEN-losing cell lines are sensitive to MK-2206, which exhibits anti-cancer effects.
Molekulargewicht:
443.94
CAS Nummer:
[1032349-77-1]
Formel:
C25H22ClN5O
Target-Kategorie:
Akt|||Others|||Apoptosis|||Autophagy
T62609
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten